Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeLorenzo Gerratana, Grazia Arpino, Mario Giuliano et al.|Cancer Treatment Reviews|2018Cited by 282
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?Giuseppe Buono, Fabio Puglisi, Lorenzo Gerratana et al.|Cancer Treatment Reviews|2019Cited by 124